Bivalent molecules that form an activating complex with an erythropoietin receptor
US6103879A · kind A · utility
17Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 1997 |
| Grant date | Aug 15, 2000 |
| Priority date | — |
| Expiry date | Jun 16, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies and Bivalent molecules which activate erythropoietins and induce the proliferation or differentiation of erythroid progenitor cells are provided. Also provided are methods of using such bivalent molecules for drug discovery, diagnosis and treatment of disorders related to the activation of an erythropoietin receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.